← Leaderboards
Dissou Affolabi
Nat'L Hospital/Tuberculosis/Pul/Diseases
$1,446,653
Attributed
$1,446,653
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $558.2K · FY2012–16$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,446,653 · 2
By mechanism
U01$1,446,653 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Guinea”
- Elizabeth Baseler · Leidos Biomedical Research, Inc.$40,046,035
- Robert F Garry · Scripps Research Institute, The$36,310,668
- Beth Baseler · Leidos Biomedical Research, Inc.$30,337,006
- Marcus Aaron Horwitz · University Of California San Francisco$21,778,221
- Sean M Amberg · Kineta, Inc.$18,993,187
- Stephen Lev Hoffman · Sanaria, Inc.$18,682,365
Research focus
GuineaHeterogeneityAfricaGenome-WideAfrica South Of The SaharaCessation Of LifeAfricanCollaborationsGenetic AnalysisCountryCellsDrug ExposureDrug KineticsDrug MetabolismCharacteristicsEnrollmentEnzymesEthambutolComplexBiologicalGatifloxacinGenesGeneticHiv Seropositivity
Grant awards (5)
Contribution of genetic variation to pharmacokinetic variability and toxicity in$558,233
U01 · FY2016 · AI · contact PI
Contribution of genetic variation to pharmacokinetic variability and toxicity in$295,011
U01 · FY2015 · AI · contact PI
Contribution of genetic variation to pharmacokinetic variability and toxicity in$288,409
U01 · FY2014 · AI · contact PI
Contribution of genetic variation to pharmacokinetic variability and toxicity in$5,000
U01 · FY2013 · AI · contact PI
Contribution of genetic variation to pharmacokinetic variability and toxicity in$300,000
U01 · FY2012 · HG · contact PI